1. Home
  2. PTCT vs GTLB Comparison

PTCT vs GTLB Comparison

Compare PTCT & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$63.29

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo GitLab Inc.

GTLB

GitLab Inc.

HOLD

Current Price

$47.82

Market Cap

5.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
GTLB
Founded
1998
2011
Country
United States
United States
Employees
991
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.5B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
PTCT
GTLB
Price
$63.29
$47.82
Analyst Decision
Buy
Buy
Analyst Count
17
27
Target Price
★ $80.65
$37.17
AVG Volume (30 Days)
918.2K
★ 5.3M
Earning Date
05-07-2026
06-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 264.48
N/A
EPS
★ 0.90
N/A
Revenue
$264,734,000.00
★ $955,224,000.00
Revenue This Year
N/A
$18.72
Revenue Next Year
$17.70
$16.05
P/E Ratio
$69.20
★ N/A
Revenue Growth
★ 36.19
25.81
52 Week Low
$58.90
$18.73
52 Week High
$90.87
$55.55

Technical Indicators

Market Signals
Indicator
PTCT
GTLB
Relative Strength Index (RSI) 34.72 56.12
Support Level N/A $46.01
Resistance Level $68.93 $50.67
Average True Range (ATR) 1.97 1.69
MACD -0.32 -0.46
Stochastic Oscillator 22.43 40.88

Price Performance

Historical Comparison
PTCT
GTLB

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About GTLB GitLab Inc.

GitLab Inc operates on an all-remote model. GitLab is a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation, following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, & the Asia Pacific. It focused on accelerating innovation & broadening the distribution of its platform to companies across the world.

Share on Social Networks: